Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Intercept Pharmaceuticals, Inc.

TRADE

NASDAQ: ICPTHealthcare / Biotechnology / USA
107.62+6.09+6.00%Vol 392 6611Y Perf 59.69%
Oct 16th, 2018 16:00
BID107.63 ASK108.11
Open103.18 Previous Close101.53
Pre-Market- After-Trading108.11
 - -%  0.49 0.46%
Target Price
136.64 
Analyst Rating
Moderate Buy 2.00
Potencial %
26.97 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-100/-100/33 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-100/-100/43 
Growth Ranking
★+     40.15
Insiders Shares Cnt. % 3/6/12M
-100/-100/63 
Income Ranking
 —    -
Market Cap (mil)3 182 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
68.41 
Earnings Date
7th Nov 2018

Today's Price Range

101.87108.06

 

52wk Range

51.05133.74

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Month
-9.39%
3 Months
12.10%
6 Months
45.85%
1 Year
59.69%
3 Years
-40.62%
5 Years
79.70%

Quotes

Name / TickerPriceChg.Chg.%
ICPT107.626.09006.00
AAPL222.154.79002.20
GOOG1 121.2829.03002.66
MSFT111.003.40003.16
XOM81.200.38000.47
WFC53.730.49000.92
JNJ136.562.61001.95
FB158.785.26003.43
GE12.10-0.0500-0.41
JPM108.622.28002.14
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 6.30
Current Ratio 6.50
Long Term Debt to Total Capital 0.71
Total Debt to Equity 2.48
Interest Coverage -10.40
Leverage Ratio 476.50
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin98.70
EBIT Margin-196.00
EBITDA Margin-192.70
Pre-tax Profit Margin-6 101.60
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 20.92
PS Ratios 26.16
Price to Cash Flow -
Price to Free Cash Flow -14.40
Cash Flow Per Share -10.27
Price to Tangible Book20.92
Book Value per Share4.96
Enterprise Value (in ths.)2 891 710
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-104.22
ROE last 12 Months -212.82
Return on Assets (5Y Avg) -44.84
ROA last 12 Months -55.18
Return on Capital (5Y Avg) -88.16
ROC last 12 Months -60.46
Return on invested Capital Q -16.55
Return on invested Capital Y-64.39
Assets Turnover0.20
Receivables Turnover6.90
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)117 225
Revenue per Share 3.97
Revenue Growth 3 Years 254.49
Revenue Growth 5 Years 156.09
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-2.83-2.588.83
Q01 2018-3.41-3.225.57
Q04 2017-3.57-4.43-24.09
Q03 2017-3.55-2.8918.59
Q02 2017-3.62-3.464.42
Q01 2017-4.27-3.6115.46
Q04 2016-3.58-4.84-35.20
Q03 2016-3.72-3.593.49
Earnings Per EndEstimateRevision %Trend
9/2018 QR-2.652.21Positive
12/2018 QR-2.630.00-
12/2018 FY-10.566.80Positive
12/2019 FY-8.02-0.12Negative
Next Report Date7th Nov 2018
Estimated EPS Next Report-2.65
Estimates Count9
EPS Growth Next 5 Years %-
Volume Overview
Volume392 661
Shares Outstanding (in ths.)29 570
Trades Count1 617
Dollar Volume32 927 956
Avg. Volume689 984
Avg. Weekly Volume401 740
Avg. Monthly Volume494 555
Avg. Quarterly Volume484 622

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

54%46%

Bearish Bullish

49%51%

Bearish Bullish

70%30%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
6 (50.00 %)
7 (50.00 %)
7 (50.00 %)
Moderate Buy
1 (8.33 %)
0 (0.00 %)
1 (7.14 %)
Hold
4 (33.33 %)
6 (42.86 %)
5 (35.71 %)
Moderate Sell
1 (8.33 %)
1 (7.14 %)
1 (7.14 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
2.00
Moderate Buy
2.07
Moderate Buy
2.00

There are no comments yet.

News

x